Christophe Le Tourneau has been appointed as a senior Medical Oncologist at the Institut Curie in November 2009. He is heading the Early Phase Clinical Trials Program as well as the Head and Neck Clinic. He is also involved in precision medicine clinical trials, having been the PI of the SHIVA trial. Christophe Le Tourneau was certified in Medical Oncology in 2005 and got his PhD in Clinical Epidemiology in 2007. He did a 2-year Clinical Research Fellowship at Princess Margaret Hospital in Toronto, Canada, in the Drug Development Program. His main interests are precision medicine, phase I clinical trials with a special attention at the methodology to conduct these trials, as well as Head and Neck oncology. Christophe Le Tourneau is the principal investigator of several phase I trials, as well as of clinical trials in Head and Neck oncology. He has published over 85 peer-reviewed papers in international journals.